{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T21:26:00Z","timestamp":1781731560515,"version":"3.54.5"},"reference-count":39,"publisher":"BMJ","issue":"8","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child"],"accepted":{"date-parts":[[2025,2,8]]},"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:p>Varicella, known as chickenpox, is caused by the varicella zoster virus (VZV), with an estimated 84 million cases annually. It primarily affects children, for most of whom it is a self-limiting illness. However, there are an estimated 950\u2009000 disability-adjusted life years attributed to VZV annually, disproportionately affecting lower-income settings. Children with impaired immunity and neonates are particularly at risk for severe varicella. Epidemiology varies between tropical and temperate regions with infections occurring at an earlier age in temperate climates.<\/jats:p>\n               <jats:p>Varicella is a vaccine-preventable disease and over 40 countries have a universal one-dose or two-dose paediatric immunisation programme, either administered alone or combined with the measles, mumps and rubella vaccination (MMRV). The UK\u2019s Joint Committee on Vaccination and Immunisation recommended the introduction of MMRV in November 2024. The vaccine, whether monovalent or MMRV, is effective in reducing varicella cases and hospital admissions, and two-dose regimens have further reduced breakthrough infections of shingles, a recognised concern in varicella vaccination programmes. Long-term data on shingles incidence in later life are not yet available and may be mitigated through paired universal shingles vaccination programmes for adults.<\/jats:p>\n               <jats:p>Cost-effectiveness studies in high-resource settings support vaccination due to reduced hospitalisations and societal costs, such as missed caregiver employment. However, more research is needed for lower-resource regions to determine whether universal vaccination is feasible and cost-effective. While global varicella elimination is unlikely without sterilising immunity, vaccination can significantly reduce the disease burden, depending on regional epidemiology and available resources.<\/jats:p>","DOI":"10.1136\/archdischild-2024-327593","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T13:20:16Z","timestamp":1740057616000},"page":"586-591","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Varicella: is it time for a global vaccination programme?"],"prefix":"10.1136","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2423-1682","authenticated-orcid":false,"given":"Eva Louise","family":"Wooding","sequence":"first","affiliation":[{"name":"MRC Centre for Medical Mycology, Exeter, UK"},{"name":"University Hospitals Plymouth NHS Trust Neonatal Intensive Care Unit, Plymouth, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seilesh","family":"Kadambari","sequence":"additional","affiliation":[{"name":"Department of Paediatric Infectious Diseases and Immunology, Great Ormond Street Hospital for Children, London, London, UK"},{"name":"Department of Paediatrics, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adilia","family":"Warris","sequence":"additional","affiliation":[{"name":"Department of Paediatric Infectious Diseases and Immunology, Great Ormond Street Hospital for Children, London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,2,20]]},"reference":[{"key":"2025071802100769000_110.8.586.1","first-page":"265","article-title":"Varicella and herpes zoster vaccines","volume":"89","year":"2014","journal-title":"Wkly Epidemiol Rec"},{"key":"2025071802100769000_110.8.586.2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/172.3.706"},{"key":"2025071802100769000_110.8.586.3","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-023-00899-7"},{"key":"2025071802100769000_110.8.586.4","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2007.123232"},{"key":"2025071802100769000_110.8.586.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.07.036"},{"key":"2025071802100769000_110.8.586.6","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268800068308"},{"key":"2025071802100769000_110.8.586.7","unstructured":"Lopez A , Harrington T , Marin M . Chapter 22: varicella. In: Pink book. Centre for Disease Control, Available: https:\/\/www.cdc.gov\/pinkbook\/hcp\/table-of-contents\/chapter-22-varicella.html?CDC_AAref_Val=https:\/\/www.cdc.gov\/vaccines\/pubs\/pinkbook\/varicella.html"},{"key":"2025071802100769000_110.8.586.8","unstructured":"Sylvia H Y . Varicella-zoster virus infections. In: Elaine C , Jong D , Stevens L , eds. Netter\u2019s infectious diseases. 2nd edn. Philadelphia, USA: Elsevier,"},{"key":"2025071802100769000_110.8.586.9","first-page":"95","article-title":"Varicella-zoster virus infection: natural history, clinical manifestations, immunity and current and future vaccination strategies","volume":"41","author":"Freer","year":"2018","journal-title":"New Microbiol"},{"key":"2025071802100769000_110.8.586.10","unstructured":"Leung JHT , Dooling K . Chapter 24: zoster. In: Pink Book. Centre for Disease Control, 2024. Available: https:\/\/www.cdc.gov\/pinkbook\/hcp\/table-of-contents\/chapter-23-zoster.html"},{"key":"2025071802100769000_110.8.586.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2012.06.002"},{"key":"2025071802100769000_110.8.586.12","doi-asserted-by":"publisher","DOI":"10.1542\/peds.56.3.388"},{"key":"2025071802100769000_110.8.586.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(96)70427-4"},{"key":"2025071802100769000_110.8.586.14","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy403"},{"key":"2025071802100769000_110.8.586.15","doi-asserted-by":"crossref","DOI":"10.1542\/peds.105.5.e60","article-title":"Invasive Group A Streptococcal Disease in Children and Association With Varicella-Zoster Virus Infection","volume":"105","author":"Laupland","year":"2000","journal-title":"Pediatrics"},{"key":"2025071802100769000_110.8.586.16","doi-asserted-by":"crossref","DOI":"10.1542\/peds.108.5.e79","article-title":"Severe complications of varicella in previously healthy children in Germany: a 1-year survey","volume":"108","author":"Ziebold","year":"2001","journal-title":"Pediatrics"},{"key":"2025071802100769000_110.8.586.17","doi-asserted-by":"publisher","DOI":"10.1086\/315714"},{"key":"2025071802100769000_110.8.586.18","doi-asserted-by":"publisher","DOI":"10.1007\/s00430-006-0032-z"},{"key":"2025071802100769000_110.8.586.19","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(02)02059-8"},{"key":"2025071802100769000_110.8.586.20","unstructured":"United Kingdom Health Security Agency (2024) . Guidance on post exposure prophylaxis (pep) for varicella or chickenpox (october 2024). Available: https:\/\/www.gov.uk\/government\/publications\/post-exposure-prophylaxis-for-chickenpox-and-shingles\/guidelines-on-post-exposure-prophylaxis-pep-for-varicella-or-shingles-january-2023#infants-and-neonates [Accessed 7 Oct 2024]."},{"key":"2025071802100769000_110.8.586.21","unstructured":"World Health Organization (2024) . Introduction of varicella vaccine. Available: https:\/\/immunizationdata.who.int\/global\/wiise-detail-page\/introduction-of-varicella-vaccine?ISO_3_CODE=&YEAR= [Accessed 16 Sep 2024]."},{"key":"2025071802100769000_110.8.586.22","unstructured":"SAGE Working Group on Varicella and Herpes Zoster Vaccines . Background paper on herpes zoster vaccines. Available: https:\/\/terrance.who.int\/mediacentre\/data\/sage\/SAGE_Docs_Ppt_Apr2014\/6_session_varicella_herpes_zoster\/Apr2014_session6_herpes_zoster.pdf [Accessed 1 Oct 2024]."},{"key":"2025071802100769000_110.8.586.23","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268814002222"},{"key":"2025071802100769000_110.8.586.24","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.13.132142"},{"key":"2025071802100769000_110.8.586.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.08.008"},{"key":"2025071802100769000_110.8.586.26","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1788861"},{"key":"2025071802100769000_110.8.586.27","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001721","article-title":"Combination Measles-Mumps-Rubella-Varicella Vaccine in Healthy Children: A Systematic Review and Meta-analysis of Immunogenicity and Safety","volume":"94","author":"Ma","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"2025071802100769000_110.8.586.28","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2023.2252065"},{"key":"2025071802100769000_110.8.586.29","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy1099"},{"key":"2025071802100769000_110.8.586.30","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac306"},{"key":"2025071802100769000_110.8.586.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2023.01.027"},{"key":"2025071802100769000_110.8.586.32","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-017-2815-9","article-title":"Varicella zoster virus-associated morbidity and mortality in Africa - a systematic review","volume":"17","author":"Hussey","year":"2017","journal-title":"BMC Infect Dis"},{"key":"2025071802100769000_110.8.586.33","unstructured":"Joint Committee on Vaccination and Immunisation . Minutes of the meeting held on 14 october 2009. Available: https:\/\/webarchive.nationalarchives.gov.uk\/ukgwa\/20130107105354\/http:\/\/www.dh.gov.uk\/prod_consum_dh\/groups\/dh_digitalassets\/@dh\/@ab\/documents\/digitalasset\/dh_109874.pdf [Accessed 1 Oct 2024]."},{"key":"2025071802100769000_110.8.586.34","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac251"},{"key":"2025071802100769000_110.8.586.35","first-page":"2950","article-title":"Economic burden of varicella complications in two referral centers in Mexico","volume":"14","author":"Macias-Parra","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"2025071802100769000_110.8.586.36","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-021-12343-x","article-title":"Economic burden of varicella in Europe in the absence of universal varicella vaccination","volume":"21","author":"Pawaskar","year":"2021","journal-title":"BMC Public Health"},{"key":"2025071802100769000_110.8.586.37","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.k4029","article-title":"Efficacy, effectiveness, and safety of herpes zoster vaccines in adults aged 50 and older: systematic review and network meta-analysis","volume":"363","author":"Tricco","year":"2018","journal-title":"BMJ"},{"key":"2025071802100769000_110.8.586.38","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-017-2445-2","article-title":"Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization","volume":"17","author":"Riera-Montes","year":"2017","journal-title":"BMC Infect Dis"},{"key":"2025071802100769000_110.8.586.39","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-068611","article-title":"Epidemiology of hospitalisations due to chickenpox and quality of life lost in community and hospital settings: protocol for a prospective cohort study across two countries","volume":"13","author":"Marlow","year":"2023","journal-title":"BMJ Open"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2024-327593","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T09:10:23Z","timestamp":1752829823000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/archdischild-2024-327593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,20]]},"references-count":39,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,7,18]]},"published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10.1136\/archdischild-2024-327593"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2024-327593","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"value":"0003-9888","type":"print"},{"value":"1468-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,20]]}}}